Citation:Gaddam S, Singh M, Balasubramanian G, Gupta N, Wani S, Higbee AD, et al 2013

From Cancer Guidelines Wiki

Citation


Gaddam S, Singh M, Balasubramanian G, Gupta N, Wani S, Higbee AD, et al. Persistence of Non-Dysplastic Barrett's Esophagus Identifies Patients at Lower Risk for Esophageal Adenocarcinoma-Results from a Large Multicenter Cohort. Gastroenterology 2013 May 25 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/23714382.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
What is the incidence of neoplasia in patients with BO?Associate Professor Freddy Sitascompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted

Compare quality appraisals for each clinical question

Cited by

  1. What is the incidence of neoplasia in patients with BO?